Duke researchers are testing the safety and effectiveness of 2% Benzydamine HCL vaginal gel for bacterial vaginosis (BV) treatment.

Eligibility

We are seeking women who:

• Are between ages 18 and 50
• Are not pregnant or nursing
• Have BV

Requirements

Participants will receive the study drug and make three clinical visits in one month, with each visit lasting an hour or less.

Compensation

Participants will receive $110 and two exam visits.